心臓アブレーション装置:医療機器パイプライン分析

◆英語タイトル:Cardiac Ablation Devices - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0168
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:115
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥424,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥848,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD12,000 ⇒換算¥1,272,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Cardiac Ablation Devices – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Cardiac Ablation Devices – Medical Devices Pipeline Assessment, 2019″ provides an overview of Cardiac Ablation Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Ablation Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiac Ablation Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiac Ablation Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiac Ablation Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Cardiac Ablation Devices Overview 8
3 Products under Development 9
3.1 Cardiac Ablation Devices – Pipeline Products by Stage of Development 9
3.2 Cardiac Ablation Devices – Pipeline Products by Territory 10
3.3 Cardiac Ablation Devices – Pipeline Products by Regulatory Path 11
3.4 Cardiac Ablation Devices – Pipeline Products by Estimated Approval Date 12
3.5 Cardiac Ablation Devices – Ongoing Clinical Trials 13
4 Cardiac Ablation Devices – Pipeline Products under Development by Companies 14
4.1 Cardiac Ablation Devices Companies – Pipeline Products by Stage of Development 14
4.2 Cardiac Ablation Devices – Pipeline Products by Stage of Development 15
5 Cardiac Ablation Devices Companies and Product Overview 16
5.1 AblaCor Medical Corporation Company Overview 16
5.1.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Adagio Medical Inc. Company Overview 18
5.2.1 Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
5.3 AFreeze GmbH Company Overview 21
5.3.1 AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 AngioDynamics Inc Company Overview 25
5.4.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.5 Atrian Medical Ltd Company Overview 26
5.5.1 Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
5.6 AtriCure Inc Company Overview 27
5.6.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 Baylis Medical Company Inc Company Overview 32
5.7.1 Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview 32
5.8 Corfigo Inc Company Overview 33
5.8.1 Corfigo Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.9 Coridea, LLC Company Overview 34
5.9.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 34
5.10 CPSI Biotech Company Overview 35
5.10.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 35
5.11 Helical Solutions, Inc. (Inactive) Company Overview 39
5.11.1 Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 39
5.12 Johns Hopkins University Company Overview 40
5.12.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 40
5.13 Kardium Inc Company Overview 42
5.13.1 Kardium Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.14 LuxCath, LLC Company Overview 43
5.14.1 LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview 43
5.15 Medtronic plc Company Overview 44
5.15.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 44
5.16 Northwestern University Company Overview 49
5.16.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 49
5.17 Sheba Medical Center Company Overview 50
5.17.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 50
5.18 Spectranetics Corp Company Overview 51
5.18.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 51
5.19 Thermedical Inc Company Overview 52
5.19.1 Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview 52
5.20 Tufts Medical Center Company Overview 55
5.20.1 Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview 55
5.21 University of California Los Angeles Company Overview 56
5.21.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 56
5.22 University of Chicago Company Overview 57
5.22.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 57
5.23 VytronUS Inc Company Overview 58
5.23.1 VytronUS Inc Pipeline Products & Ongoing Clinical Trials Overview 58
6 Cardiac Ablation Devices- Recent Developments 62
6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 62
6.2 Nov 18, 2019: Biosense Webster launches a two-pronged initiative to tackle the new millennium epidemic of Atrial Fibrillation 64
6.3 Nov 14, 2019: Stereotaxis reports 2019 third quarter financial results 65
6.4 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 66
6.5 Nov 08, 2019: Stereotaxis and Catheter Precision combine robotic navigation and preoperative arrhythmia localization to treat cardiac arrhythmias 67
7 Appendix 112
7.1 Methodology 112
7.2 About GlobalData 115
7.3 Contact Us 115
7.4 Disclaimer 115

List of Tables
Table 1: Cardiac Ablation Devices - Pipeline Products by Stage of Development
Table 2: Cardiac Ablation Devices - Pipeline Products by Territory
Table 3: Cardiac Ablation Devices - Pipeline Products by Regulatory Path
Table 4: Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
Table 5: Cardiac Ablation Devices - Ongoing Clinical Trials
Table 6: Cardiac Ablation Devices Companies - Pipeline Products by Stage of Development
Table 7: Cardiac Ablation Devices - Pipeline Products by Stage of Development
Table 8: AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AutoBlator - Product Status
Table 10: AutoBlator - Product Description
Table 11: CircumBlator AF Catheter Ablation System - Product Status
Table 12: CircumBlator AF Catheter Ablation System - Product Description
Table 13: Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 14: iCLAS System - Product Status
Table 15: iCLAS System - Product Description
Table 16: Adagio Medical Inc. - Ongoing Clinical Trials Overview
Table 17: iCLAS System - A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients with Atrial Fibrillation
Table 18: iCLAS System - iCLAS for Persistent Atrial Fibrillation
Table 19: AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 20: CoolLoop - Product Status
Table 21: CoolLoop - Product Description
Table 22: Tip-Catheter - Product Status
Table 23: Tip-Catheter - Product Description
Table 24: AFreeze GmbH - Ongoing Clinical Trials Overview
Table 25: CoolLoop - Treatment Success with the CoolLoop Cryoablation System - Post-Market Surveillance
Table 26: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Non-Thermal Vein Ablation Device - Product Status
Table 28: Non-Thermal Vein Ablation Device - Product Description
Table 29: Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 30: mPEF Device - Atrial Fibrillation - Product Status
Table 31: mPEF Device - Atrial Fibrillation - Product Description
Table 32: AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: AtriCure Bipolar System - Product Status
Table 34: AtriCure Bipolar System - Product Description
Table 35: cryoICE Ablation System - Atrial Fibrillation - Product Status
Table 36: cryoICE Ablation System - Atrial Fibrillation - Product Description
Table 37: AtriCure Inc - Ongoing Clinical Trials Overview
Table 38: AtriCure Bipolar System - Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation
Table 39: cryoICE Ablation System - Atrial Fibrillation - AtriCure CryoIce Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment during Concomitant On-Pump Endo/Epicardial Cardiac Surgery
Table 40: Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Cardiac Ablation Mitigating Device - Product Status
Table 42: Cardiac Ablation Mitigating Device - Product Description
Table 43: Corfigo Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 44: HeArTPAD - Product Status
Table 45: HeArTPAD - Product Description
Table 46: Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Cardiac Sympathetic Denervation Device - Product Status
Table 48: Cardiac Sympathetic Denervation Device - Product Description
Table 49: CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
Table 50: ICEolate Catheter - Product Status
Table 51: ICEolate Catheter - Product Description
Table 52: ICEolate Catheter With Spot Ablation Tip - Product Status
Table 53: ICEolate Catheter With Spot Ablation Tip - Product Description
Table 54: ICEolate Surgical Probe With Control Handle - Product Status
Table 55: ICEolate Surgical Probe With Control Handle - Product Description
Table 56: ICEolate Surgical Probe With Flexible Ablation Tip - Product Status
Table 57: ICEolate Surgical Probe With Flexible Ablation Tip - Product Description
Table 58: Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Catheter-Based Ablation Device - Product Status
Table 60: Catheter-Based Ablation Device - Product Description
Table 61: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Catheter Guiding Computational Modeling Tool - Product Status
Table 63: Catheter Guiding Computational Modeling Tool - Product Description
Table 64: Oscillatory Atherectomy Device - Product Status
Table 65: Oscillatory Atherectomy Device - Product Description
Table 66: Kardium Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Globe Mapping And Ablation System - Product Status
Table 68: Globe Mapping And Ablation System - Product Description
Table 69: LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview

List of Figures
Figure 1: Cardiac Ablation Devices - Pipeline Products by Stage of Development
Figure 2: Cardiac Ablation Devices - Pipeline Products by Territory
Figure 3: Cardiac Ablation Devices - Pipeline Products by Regulatory Path
Figure 4: Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
Figure 5: Cardiac Ablation Devices - Ongoing Clinical Trials

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[心臓アブレーション装置:医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆